Business Segments Roche Holding AG Swiss Exchange

Stocks

Market Closed - Swiss Exchange Other stock markets 09:01:26 10/06/2026 pm IST			5-day change	1st Jan Change
323.90 ^CHF	+1.60%		+2.94%	-1.31%

10/06	Organon wins US approval to widen use of arthritis biosimilar drug	RE
10/06	Lilly stays ahead of the pack as rivals jump on obesity drug bandwagon	RE

Breakdown by Business Segment (CHF)

Fiscal Period: December	2021	2022	2023	2024	2025
Pharmaceutical Products
Pharmaceuticals - Roche Pharmaceuticals	4.57TCr	4.64TCr	4.44TCr	4.63TCr	4.81TCr
Total Assets	4.49TCr	4.3TCr	4.61TCr	4.55TCr	4.83TCr
CAPEX	-278.8Cr	-229.8Cr	-312.4Cr	-130.9Cr	-121.3Cr
D&A	266.1Cr	213.5Cr	181.8Cr	172.1Cr	164.2Cr
Operating Income	1.26TCr	1.13TCr	1.39TCr	1.87TCr	2.03TCr
Pharmaceuticals - Chugai	835.8Cr	927.2Cr	720.3Cr	688.2Cr	702.4Cr
Total Assets	789.2Cr	889Cr	658.9Cr	638.3Cr	666.4Cr
CAPEX	-73Cr	-53Cr	-49Cr	-31Cr	-35Cr
D&A	25Cr	22Cr	20Cr	18Cr	18Cr
Operating Income	352.5Cr	398.8Cr	291.5Cr	328.3Cr	334.6Cr
EBITDA	1.99TCr	2.07TCr	2.14TCr	2.34TCr	2.48TCr
Medical Testing, Analyzing, and Diagnostic Equipment
Diagnostics	1.79TCr	1.78TCr	1.42TCr	1.45TCr	1.4TCr
Total Assets	2.15TCr	2.16TCr	2.05TCr	2.26TCr	2.16TCr
CAPEX	-178Cr	-176.2Cr	-198.3Cr	-181Cr	-200.9Cr
EBITDA	531Cr	480.5Cr	388.3Cr	369.5Cr	333.7Cr
D&A	146.3Cr	141.9Cr	137.3Cr	145.3Cr	150.2Cr
Operating Income	331.9Cr	332.4Cr	217.1Cr	240.2Cr	199.8Cr
Elimination	-607.7Cr	-701.8Cr	-535.4Cr	-529.2Cr	-570Cr
Total Assets	-407.5Cr	-463.4Cr	-302.6Cr	-298Cr	-374.3Cr
Operating Income	-60Cr	-50Cr	35Cr	3.8Cr	-20Cr
Total Assets	-	-	-	-	-
Total Assets	685Cr	499.1Cr	537.6Cr	697.5Cr	558.2Cr
Total Assets	618.1Cr	477.6Cr	513.4Cr	1.03TCr	989.4Cr
Operating Income	-69Cr	-66Cr	-390.8Cr	-359.3Cr	-360.5Cr
D&A	7Cr	6.9Cr	7.7Cr	7.2Cr	6.7Cr
EBITDA	-51Cr	-49Cr	-334Cr	-352.1Cr	-353.4Cr
CAPEX	-10Cr	-9.2Cr	-8.8Cr	-6.9Cr	-4.5Cr
Total Assets	42Cr	44Cr	56Cr	63Cr	67Cr

Geographical breakdown of sales (CHF)

Fiscal Period: December	2021	2022	2023	2024	2025
United States	2.81TCr	2.93TCr	2.84TCr	3.02TCr	3.07TCr
Total Assets	2.55TCr	2.36TCr	2.64TCr	2.73TCr	2.76TCr
CAPEX	-92Cr	-88Cr	-127.6Cr	-109.9Cr	-99Cr
Rest of Europe	1.14TCr	1.03TCr	970.3Cr	1.03TCr	1.09TCr
Total Assets	207.1Cr	184.8Cr	167.3Cr	201.4Cr	208.5Cr
CAPEX	-34Cr	-28Cr	-31Cr	-32Cr	-46Cr
China	-	-	-	-	481.5Cr
Total Assets	-	-	-	-	73Cr
CAPEX	-	-	-	-	-13Cr
Rest of Asia	976.2Cr	985.2Cr	889Cr	908.5Cr	378.4Cr
Total Assets	165.6Cr	152.6Cr	141Cr	148Cr	72Cr
CAPEX	-29Cr	-30Cr	-32Cr	-31Cr	-28Cr
Latin America	274.6Cr	287Cr	297.1Cr	324.9Cr	324.5Cr
Total Assets	33Cr	37Cr	42Cr	46Cr	46Cr
CAPEX	-12Cr	-14Cr	-19Cr	-18Cr	-15Cr
Germany	431.9Cr	331.8Cr	289.3Cr	293.8Cr	312.2Cr
Total Assets	535.5Cr	532.2Cr	525.8Cr	549.1Cr	561Cr
CAPEX	-64Cr	-67Cr	-61Cr	-61Cr	-67Cr
Japan	506.9Cr	645.2Cr	446.4Cr	329.1Cr	311.9Cr
Total Assets	306.3Cr	292.6Cr	269.7Cr	271.9Cr	267.8Cr
CAPEX	-61Cr	-46Cr	-45Cr	-32Cr	-36Cr
Africa, Australia and Oceania	147.5Cr	152Cr	121.2Cr	125Cr	136Cr
Total Assets	14Cr	14Cr	13Cr	15Cr	15Cr
CAPEX	-4.5Cr	-4Cr	-4.4Cr	-5.6Cr	-4.2Cr
Switzerland	211.7Cr	167.1Cr	111.8Cr	123Cr	134.5Cr
Total Assets	911.2Cr	897.6Cr	912Cr	908.1Cr	953.9Cr
CAPEX	-86Cr	-64Cr	-56Cr	-60Cr	-52Cr
Rest of North America	92Cr	110.2Cr	84Cr	89Cr	98Cr
Total Assets	5.8Cr	5.1Cr	4.1Cr	20Cr	19Cr
CAPEX	-20L	-30L	-50L	-60L	-1.2Cr